IVI RMA, Basking Ridge, New Jersey.
Yale School of Medicine, New Haven, Connecticut, USA.
Curr Opin Obstet Gynecol. 2021 Jun 1;33(3):184-187. doi: 10.1097/GCO.0000000000000707.
To discuss the utilization, performance, and interpretation of noninvasive prenatal testing (NIPT) results in women achieving pregnancy through in vitro fertilization (IVF) and preimplantation genetic testing for aneuploidy (PGT-A).
Although PGT-A is a highly accurate method for the selection of euploid embryos the possibility for error still exists. Many women pursue NIPT after conception via IVF with or without PGT-A, whereas some forgo prenatal screening all together. Recent evidence suggests that the prevalence of a positive NIPT following PGT-A is low, and the positive predictive value is altered in this population.
NIPT is a valuable prenatal screening tool that should be offered to pregnant women regardless of prior PGT. In women who conceive following IVF and PGT-A through the transfer of euploid embryos, positive test results should be interpreted with caution.
讨论通过体外受精 (IVF) 和非整倍体胚胎植入前遗传学检测 (PGT-A) 实现妊娠的妇女对无创产前检测 (NIPT) 结果的利用、性能和解读。
尽管 PGT-A 是选择整倍体胚胎的一种高度准确的方法,但仍然存在出错的可能性。许多女性在接受 IVF 后进行 NIPT 检测,无论是否进行 PGT-A,而有些女性则完全放弃了产前筛查。最近的证据表明,PGT-A 后 NIPT 的阳性率较低,并且在该人群中阳性预测值发生了改变。
NIPT 是一种有价值的产前筛查工具,无论之前是否进行 PGT,都应提供给孕妇。在通过移植整倍体胚胎进行 IVF 和 PGT-A 后怀孕的妇女中,阳性检测结果应谨慎解读。